Infant colic is a pediatric disorder of unknown etiology. Colic is
characterized by excessive crying and it affects 20% of U.S. infants,
whether breast-fed or formula-fed. Colic is important because of infant
pain, parental frustration with inconsolable crying, some infant abuse
mortality, pediatrician effort, expense, and lack of effective treatment.
Since levels of bovine IgG (BGG) in infant formulas and human milk are
comparable, and breast milk BGG levels seems to correlated with colic,
an investigation of whether dietary BGG might be a major cause of colic
is proposed. BGG is the major foreign immunoglobulin in the human diet
(often 500 mg/day) and has unique properties of intentional transport,
stability, binding to Fc receptors, and immunomodulation. In vitro
studies suggest that BGG may profoundly influence the developing mucosal
immune system and might initiate colic and certain inflammatory diseases.
As one immediate goal, this hypothesis will be tested directly by
conducting double-blind placebo-controlled trials comparing infant
responses after ingestion of BGG and placebo. Both breast-fed infants
and formula-fed infants will be tested and colic responses will be
assessed by simplified cry diaries. The effect of maternal consumption
of diary products on breast milk levels of BGG and on colic in breast-fed
infants will also be studied. Since preliminary data show elevated
levels of serum BGG in patients with various forms of colitis, a second
goal is to determine whether BGG plays an important role in milk-induced
colitis, ulcerative colitis, and eosinophilic gastroenteritis. This will
be carried out by analyzing sera of patients during exacerbations of
these disorders for levels of BGG will be assessed by RAST assay.
Another goal is to better understand how BGG is selectively transported
and how BGG may cause colic or other diseases in susceptible individuals.
Whether intestinal FcR account for selective BGG absorption will be
studied in an animal model using a FcR-deficient mouse strain. How and
when selective BGG transport occurs i humans will be investigated by
measuring milk and serum levels of BGG at various stages of pregnancy and
lactation. A knowledge of the role of ingested bovine IgG in colic and
other disorders may lead to better methods of prevention and treatment.
This research might also provide insights into etiology of autoimmune
diseases (rheumatoid arthritis, Type I diabetes).
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
antibody receptorantigensbaby foodbreast feedingclinical trialscolitiscryingsdairy productsdevelopmental nutritionfood hypersensitivitygastroenteritisgastrointestinal disorderhuman milkhuman subjectimmunoglobulin Eimmunoglobulin Ginfant human (0-1 year)laboratory mouselactationnutrition related tagpainpregnancyserology /serodiagnosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
068552207
UEI
L6NFUM28LQM5
Project Start Date
01-January-1994
Project End Date
28-February-1999
Budget Start Date
01-March-1997
Budget End Date
28-February-1999
Project Funding Information for 1997
Total Funding
$176,611
Direct Costs
$113,324
Indirect Costs
$63,287
Year
Funding IC
FY Total Cost by IC
1997
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$176,611
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01HD029420-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HD029420-04
Patents
No Patents information available for 5R01HD029420-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HD029420-04
Clinical Studies
No Clinical Studies information available for 5R01HD029420-04
News and More
Related News Releases
No news release information available for 5R01HD029420-04
History
No Historical information available for 5R01HD029420-04
Similar Projects
No Similar Projects information available for 5R01HD029420-04